Combining GLP-1 Drugs With Other Diabetes Medications: What Works Best
Incretin-based drugs (GLP-1 agonists, DPP-4 inhibitors) combine effectively with metformin, sulfonylureas, and insulin for type 2 diabetes, with optimal pairing depending on patient characteristics and treatment goals.
Quick Facts
What This Study Found
GLP-1 agonists and DPP-4 inhibitors combine synergistically with metformin (first-line), sulfonylureas, thiazolidinediones, and insulin for T2DM, with combination selection guided by patient weight, hypo risk, and HbA1c target — practical combination pharmacotherapy guidance.
Key Numbers
How They Did This
review study.
Why This Research Matters
Relevant for glp-1, diabetes.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
- ?Clinical translation to evaluate.
Trust & Context
- Key Stat:
- Key finding GLP-1 agonists and DPP-4 inhibitors combine synergistically with metformin (first-line), sulfonylureas, thiazolidinediones, and insulin for T2DM, with
- Evidence Grade:
- moderate evidence.
- Study Age:
- Published in 2008.
- Original Title:
- Combination pharmacotherapy with incretins: what works best and when?
- Published In:
- Current diabetes reports, 8(5), 361-7 (2008)
- Authors:
- Over, Rebecca K, Ratner, Robert E
- Database ID:
- RPEP-01395
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What was studied?
Combining GLP-1 Drugs With Other Diabetes Medications: What Works Best
What was found?
Incretin-based drugs (GLP-1 agonists, DPP-4 inhibitors) combine effectively with metformin, sulfonylureas, and insulin for type 2 diabetes, with optimal pairing depending on patient characteristics and treatment goals.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-01395APA
Over, Rebecca K; Ratner, Robert E. (2008). Combination pharmacotherapy with incretins: what works best and when?. Current diabetes reports, 8(5), 361-7.
MLA
Over, Rebecca K, et al. "Combination pharmacotherapy with incretins: what works best and when?." Current diabetes reports, 2008.
RethinkPeptides
RethinkPeptides Research Database. "Combination pharmacotherapy with incretins: what works best ..." RPEP-01395. Retrieved from https://rethinkpeptides.com/research/over-2008-combination-pharmacotherapy-with-incretins
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.